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Abstract
The transition of epithelial cells into a mesenchymal state (epithelial-to-mesenchymal transition or
EMT) is a highly dynamic process implicated in various biological processes. During EMT, cells do
not necessarily exist in ‘pure’ epithelial or mesenchymal states. There are cells with mixed (or hybrid)
features of the two, which are termed as the intermediate cell states (ICSs). While the exact functions
of ICS remain elusive, together with EMT it appears to play important roles in embryogenesis, tissue
development, and pathological processes such as cancer metastasis. Recent single cell experiments
and advanced mathematical modeling have improved our capability in identifying ICS and provided
a better understanding of ICS in development and disease. Here, we review the recent findings
related to the ICS in/or EMT and highlight the challenges in the identification and functional
characterization of ICS.

1. Introduction
The transition from epithelial to mesenchymal cells,
as well as the reverse (mesenchymal-to-epithelial
transition or MET), are highly dynamic processes
implicated in various biological processes. EMT is well
studied in the context of embryogenesis, organ fibrosis,
and cancer metastasis, which highlight the categorical
subtypes of EMT [1]. As our understanding of how
EMT is regulated expands, it has become clear that
EMT exists on a spectrum or continuum with various
possible cell states existing between epithelial and
mesenchymal phenotypes [2]. Cells do not necessarily
exist in ‘pure’ epithelial or mesenchymal states,
but instead can be in intermediate cell states (ICS)
or hybrid states that possess characteristics of both
epithelial and mesenchymal cells [2]. Context and
tissue specific functions of EMT exist, but a number
of key features and phenotypes are shared amongst the
different subtypes of EMT [1, 2].
EMT involves the transient reduction and sometimes full loss of adhesion between epithelial cells.
Hallmark changes include alterations in cytoskeleton
architecture, changes in cell–cell and cell-matrix adhesions, and loss of apical-basal polarities [3]. In the past,
© 2019 IOP Publishing Ltd

EMT identification had been focused on the expression of a few markers such as E-cadherin (E-cad); however, as our understanding of EMT has progressed, an
expanded view of EMT identification encompasses
multiple layers of molecular changes including EMT
transcription factors (EMT-TFs) and their gene regulatory networks that govern the transition [2]. A number of key EMT-TFs such as Snail1/Slug and Zeb1/2
have been identified in promoting the mesenchymal phenotype while other TFs such as Ovol1/2 and
Grhl2 have been shown to suppress the mesenchymal
phenotype thus promoting the epithelial phenotype
[2, 3]. EMT regulation also occurs at the microRNA,
long noncoding RNA, chromatin, and post-translational levels [2].

2. EMT in normal and diseased epithelial
tissues
The development and maintenance of epithelial
tissues is largely driven by epithelial stem cells [4].
The dynamic activities of these stem cells such as
proliferation and differentiation vary depending on
the stage of the tissue such as during development,
adult regeneration, or in pathological conditions such
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as cancer [4]. Increasing evidence implicates EMT
(and its regulation) as being another cellular dynamic
component that can promote stem cell function [2].
In general, stem cell function in adult epithelial tissues
is largely focused on the homeostatic maintenance
of the tissue where cells that are differentiated or lost
need to be replaced [4]. In line with the notion that
EMT exists in a spectrum of states and degrees, its
role can vary depending on the epithelial tissue, stage
of development, whether the tissue is undergoing
regeneration or repair, and the pathological condition
[2]. Below we highlight several instances of EMT
function and regulation in committed epithelial tissues
in different contexts such as normal development,
adult regeneration and repair, and briefly discuss in
the context of cancer (readers are referred to other
comprehensive reviews on this topic, e.g. [2]).
The normal and cancerous mammary epithelium
has been utilized as a model to study the potential role
and regulation of EMT in epithelial stem cell function. Experiments using immortalized human mammary epithelial cells provided in vitro evidence that
ectopic expression of EMT-TFs Snail1 and Twist leads
to acquisition of stem-like activities [5]. A positive
correlation between heightened EMT gene signature
and stem cell fate has also been noted for normal and
cancerous mammary epithelial cell types in culture
or directly isolated from the human or mouse tissue
[6, 7]. These data generated much interest in EMT as
they suggest a link between EMT and the gain of stemlike features.
Further work in the mammary model in vivo found
that Snai2 (Slug) is the major EMT-TF expressed in
mouse mammary basal cells known to contain multipotent stem cells, and that ectopic expression of Snai2
leads to enhanced stem-like features [8]. Moreover, knockout or knockdown of Snai2 compromises
mammary epithelial development and/or the ability
of primary mammary epithelial cells to regenerate a
mammary tree [8, 9]. Zeb1 has also been found to be
expressed in normal mouse and human mammary
basal cells [10], with expression particularly enriched
in the Procr+ stem cell subset [7]. However, its functional significance remains to be elucidated. Interestingly, using a transgenic mammary tumor model,
Snail1- but not Snai2- expressing cells appeared in the
early hyperplastic lesions as well as more high-grade
carcinomas [11]. These cells lack E-cad expression and
begin to express other EMT-TFs such as Zeb1, suggesting that Snail1 (but not Snai2) is responsible for governing the EMT program in cancer progression [11].
These observations highlight the notion that different
EMT-TFs can have different, context-specific functions even in the same tissue, and the exact underlying
molecular and cellular mechanisms may differ. Thus,
we emphasize again the importance to now expand
our view of EMT beyond a simple binary, linear or universally identical process with the end goal of gener-
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ating mesenchymal cells. EMT can be thought of as a
historical term that is redirected to describe the diverse
and complex variant forms associated with epithelialmesenchymal plasticity. Specifically, EMT may be considered a navigation through a rugged, highly nonlinear multidimensional landscape of different axes that
cumulatively define EMT [12, 13]. On this landscape,
cell states other than epithelial and mesenchymal cells
often exist, exhibiting mixed (or hybrid) features of
epithelial and mesenchymal states. Such cell states,
termed as intermediate cell states (ICSs) in this paper,
may play important roles in regulating transitions
between epithelial cells and mesenchymal cells.
Growing evidence also points to the importance of
regulating EMT during physiological epithelial development and regeneration. Within the mammary epithelium, suppression of EMT by Elf5 and Ovol2 TFs
appears to be an integral component of its normal
development and regeneration [14, 15]. Loss of Ovol2
in the mammary epithelium results in an up-regulation of a large number of EMT/mesenchymal markers
such as vimentin (Vim) and EMT-TFs such as Zeb1,
as well as in vivo morphological transformation reminiscent of EMT [15]. Importantly, many of these EMT
genes are direct targets of Ovol2’s transcriptional
repressor activity and depletion of Zeb1 rescues the
regenerative defect caused by Ovol2 deficiency [15],
underscoring an EMT-centric function of Ovol2 in the
mammary gland. Interestingly and adding to the clinical importance of EMT regulation, incidence of metastasis-free survival increases in breast cancer patients
with high levels of Ovol2 [15].
Transcriptional inhibition of EMT by Ovol2 and
its homolog, Ovol1, is also critically important for
normal skin epithelial development during embryogenesis. Loss of both Ovol2 and Ovol1 leads to defective epidermal and hair follicle morphogenesis [16].
Similar to the observations in the mammary gland,
loss of Ovol leads to up-regulated expression of EMT
structural markers and EMT-TFs, as well as EMT-like
phenotypes such as reduced adhesion between, and
aberrant migration of, embryonic epidermal cells [16].
In adult skin, loss of Ovol2 alone results in defective
wound healing [17], a process that has been proposed
to involve partial EMT of wound peripheral epidermal
cells so they can efficiently migrate to close the wound
[2, 18, 19]. Ovol2-deficient epidermal and hair follicle
stem cells migrate faster than their normal counter
parts, but with significantly reduced directionality
[17]—defects that are near-completely rescued when
EMT-TF Zeb1 is simultaneously lost. On the other
hand, loss of EMT-TF Snai2 compromises epidermal
migration after wounding, and results in a thin epidermis and transient delay of hair growth during normal
development [19–21]. Together these data suggest that
a delicate balance of EMT regulation exists to maintain
both epithelial-like and mesenchymal-like states and
this ability to toggle between the two states might be
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critical for skin epithelial development and regeneration.
The study of EMT in cancer has largely been
focused on its role in promoting invasion and
metastasis with an involvement in chemoresistance
recently demonstrated [2]; however many questions
remain unanswered. Conflicting literature exists and
the extent of EMT importance in patients’ clinical
outcomes remains unclear [2]. The roles of partial
EMT and intermediate states in the context of cancer
is still not well understood likely due to the transient
nature of these events [2, 22]. The variation of different
EMT-TFs’ expression together with the diverse cell
types in the tissues of origin adds to the complexity.
Below we delve deeper into the idea of intermediate
states and discuss relevant existing data in the contexts
of both normal and diseased cells.

3. Existence of ICS in EMT
During EMT, cells exist on a reversible spectrum, and
can toggle between ICSs, which lie between epithelial
and mesenchymal states. Several lines of evidence
using in vitro, in vivo, and computational modeling
suggest the existence of ICS.
In vitro models that have focused on using
various cell lines are largely focused on the dual
expression of epithelial and mesenchymal markers for
identification of ICS. Glomerular parietal epithelial
cells (GPECs) from adult mouse kidney adopt an
intermediate phenotype expressing both epithelial and
mesenchymal markers [23]. The MCF10A mammary
epithelial cell line exists in an ICS with expression of
both epithelial (E-cad) and mesenchymal (VIM)
markers as compared to other well characterized
breast cancer cell lines [24]. Cancerous cell lines have
also been shown to exhibit ICS. Some cells from the
human non-small-cell lung cancer cell line A549
are in an intermediate EMT state in culture based on
co-expression of VIM and SNAI2 [25]. ITGB4+ triplenegative breast cancer stem cell-enriched cells reside
in an intermediate state between ‘pure’ epithelial
and mesenchymal cells [26]. Research from a number
of groups indicates that individual carcinoma cells,
rather than all cells at a population level, can exist in
ICSs. Distinguished by the widely used cell-surface
markers resolving epithelial and mesenchymal cells,
single CD24+/CD44+ cells in tumorigenic human
mammary epithelial cells are ICS cells [27]. H1975 lung
cancer cells co-stained for both VIM and E-cad display
an ICS phenotype at a single-cell level [28]. Circulating
tumor cells from human breast cancer cell lines
captured by a microfluidic device from blood exhibit
both epithelial (MCF7 and SKBR3) and mesenchymal
(MDA-MB-231) characteristics, indicating existence
of potential ICSs [29]. The classical view of the
metastatic cascade depicts a sequence of events
including dissemination, invasion, intravasation, and
eventually extravasation, and ICS cells expressing both
3

epithelial and mesenchymal features can be observed
at these different stages; however, dissecting the exact
role that EMT plays at these stages in vivo has proven to
be difficult [2].
Findings
generated
by
modeling
and
computational approaches also support the idea
of ICS. Modeling of the microRNA (miR)-based
chimeric modules showed the miR-200/Zeb
module functions as a ternary switch, allowing an
intermediate phenotype in addition to the epithelial
and mesenchymal phenotypes [30]. Random circuit
perturbation (RACIPE), interrogating the robust
dynamical behavior of a gene regulatory network,
has identified two different types of intermediate
phenotypes when applying to a proposed 22-gene
network of EMT [31]. A topographic map using the
combination of numerical simulations of a Boolean
network model and the analysis of bulk and single-cell
gene expression data revealed multiple ICSs, separating
stable epithelial and mesenchymal states [32]. Energylandscape based methods like scEpath could also be
used to identify ICS [33] and the landscape of the free
energy changes during the EMT of lung cancer cells
suggests a stable ICS [34].
Previous studies predicted that multiple ICSs may
exist between epithelial and mesenchymal states [35],
but the number of intermediate phenotypes is still a
matter of debate [36]. Recent experiments have provided evidence for one, two and three intermediate
phenotypes from TGF-β–induced EMT in MCF10A
cells [37], ovarian carcinoma (OC) cell lines [38], and
circulating tumor cells in blood [29], respectively.
While theoretical analysis helps to predict the number
of ICSs, modeling studies have revealed that complex
EMT regulatory networks govern the existence of multiple ICSs [39]. Modeling of miRNA-based regulation
composed of a tristable circuit miR-200/Zeb driven by
the monostable module miR-34/Snail1 allowed one
intermediate EMT phenotype [30]. Ovol can modulate cellular plasticity by restricting EMT, driving MET,
expanding the existence of the ICS and turning both
EMT and MET into two-step processes based on the
mechanism-based mathematical model coupling
Ovol with the core regulatory network miR-200/Zeb
[40]. Later, two distinct intermediate phenotypes in
EMT dynamics were predicted and experimentally
validated, and were shown to be modulated by Ovol2
and the Ovol2-Zeb1 mutual inhibition circuit [24].
Recently, analysis of a mathematical model that integrates expression data with the reported Tcf21-Slug
interactions reveals one stable and two metastable
ICSs in EMT [41].

4. Roles of ICS
4.1. Stemness
Recent theoretical and experimental studies have
suggested that cells in ICSs can be more stem-like
than both ‘pure’ epithelial and mesenchymal cells.
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For example, trophoblast stem cells isolated from the
conceptuses of MAP3K4 kinase-inactive mouse (TSKI4)
cells are found to be trapped in an ICS and exhibit
properties of both EMT and stemness [42]. Other cells
at ICS states may also acquire stemness. For example, coculture of cells from E and M states actually enhances
mammosphere formation (an assay for stemness),
and the isolation of the CD24+/CD44+ hybrid E/M
cell state leads to enhanced stemness [27]. In another
example, more than 90% of CD24+ cells from kidney
GPECs show co-expression of surface markers of renal
progenitors CD24 and cadherin-11, suggesting that
these cells have acquired stem cell-like properties [23].
Mathematical modeling and computational analysis also predict that the ICS confers stemness potential. A model on three-way switch LIN28/let-7 circuit
and a model on EMT-STEM-Notch coupled circuit
both revealed a high likelihood of an ICS phenotype
(when compared with either epithelial or mesenchymal states) in gaining stemness [43, 44]. Moreover, the
ICS location in the low-dimensional gene expression
space can shift towards either end of the EMT spectrum, and a crosstalk between EMT and stem cell regulatory modules in conjunction with Notch signaling
creates a window of opportunity for stemness [44]. If
one could reduce the size of the window or shift the
window away from the mesenchymal end of the EMT
space, the tumor would be less aggressive in growth or
invasiveness [45].
ICS importance has also been analyzed in other
systems not directly related to EMT [39]. For example,
based on a five-node stochastic gene regulatory
network controlling cellular stemness, ICS is found to
significantly decrease the barrier of potential landscape
and the minimal action value along the transition path
to promote the differentiation process [46]. Clearly,
additional experimental studies are needed to clarify
the mechanistic link between ICS and stemness, the
relationship of which may be correlative rather than
casual in some cases.
4.2. Collective migration
The ability of cells in ICS to migrate in a collective
manner has been implicated during embryonic
development, wound healing and the formation of
tumor cell clusters [19, 28, 47, 48]. Cells undergoing
collective migration display some migratory
characteristics reminiscent of mesenchymal cells
while maintain epithelial characteristics, implicating
a connection to the ICS. For example, collective
migration of H1975 lung cancer cells in vitro is
associated with an ICS phenotype, and both are
impaired after depletion of EMT-inhibiting TFs [28].
Cross-talks between Tcf21 and Slug have been identified
to mediate phenotypic and migration plasticity in
high-grade serous ovarian adenocarcinoma, and ICSs
were found to be important in collective cell migration
[41]. As discussed above, our recent studies highlight
the importance of balancing the functions of EMT4

inhibiting TF Ovol2 and EMT-TF Zeb1 in achieving
directional cell migration of skin epithelial cells to
support tissue repair and regeneration [17].
4.3. Drug resistance
The ICSs in EMT have great clinical relevance as they
have been associated with drug resistance. The triplenegative breast cancer cells, which contain a number
of intermediate E/M cells in primary tumor [29],
exhibit de novo resistance to current standard therapies
such as anthracyclines and taxanes [49, 50]. However,
the underlying signaling pathways and molecular
mechanisms of the interplay between ICS and drug
resistance remain largely elusive [50].
4.4. Metastasis
The overarching role of EMT in metastasis has been
extensively studied, however the precise role of ICS
remains unclear. During the metastatic cascade, cells in
primary tumor adopt mesenchymal-like features and
are then able to leave the primary tumor and colonize in
other locations, such as in mouse breast or pancreatic
cancer models where Snail1-positive or ‘EMTing’ cells
are sometimes fully detached from epithelial islands
while losing E-cad expression [51]. The EMT-TF
Zeb1 has been shown to be important for promoting
a spectra of tumor types from mesenchymal, mixed
(possibly at ICS), and epithelial as its loss leads to a
confined epithelial state in pancreatic cancer [52]. In
vivo live cell imaging coupled with gene expression
analysis indicates that cells disseminated from
primary tumors exhibit low expression of E-cad and
enhanced expression of mesenchymal markers [53],
suggesting that those cells have characteristics of ICSs.
Interestingly, in a pancreatic cancer model, deletion
of Twist or Snail1 does not cause any alterations in
invasiveness [54], indicating cells (possibly ICS) that
lose some of the well-studied mesenchymal markers
may possess mesenchymal-like features. Along the
same lines, in a lung metastases model, although EMT
occurs within the primary epithelial tumor, the initial
lung metastases are mainly derived from non-EMT
tumor cells [55], and EMT cells do play a major role
in recurrent lung metastasis after chemotherapy [55].
Beyond the gain of mesenchymal-like features during
primary tumor dissemination, dynamic EMT gene
expression is also observed in circulating breast tumor
cells [29]. Together these data suggest that during EMT
there are cells other than mesenchymal cells showing
mesenchymal-like features with tissue and context
specific roles during metastasis. Further analysis on
such cells and their connection with ICS is important
for better understanding of metastasis.
4.5. Speculated roles of ICS: controlling noise and
dynamical robustness
Mathematical modeling and computational analysis
have shown that ICS has the ability to control noise and
increase the robustness of EMT dynamics. Increased
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number of intermediate phenotypes in the EMT system
can better attenuate the overall fluctuations of the cell
population in terms of phenotypic compositions,
thereby stabilizing a heterogeneous cell population
on the EMT spectrum, via a dynamic ODE modeling
of the population of each cell phenotype [56]. The
existence of ICS can also allow noise attenuation while
maintaining the mean of the signal [57]. In another
example using a regulatory circuit of miR-200, Zeb,
and Snail1, the ICS is observed to increase the plasticity
of cell fate and the robustness of EMT dynamics
[58]. With ICS, the EMT process can be carried out
through transition first from the epithelial state to a
ICS temporarily, and making further transition then
from the ICS to the mesenchymal state or directly
going from the epithelial state to the mesenchymal
state. Moreover, cells at ICS can go back to epithelial
state at other times, depending on the signal inputs for
flexibility [58].
4.6. Stability
The ICS of EMT has been considered ‘metastable’
[35, 59], reflecting the flexibility of these cells
to undergo or reverse the EMT process [60]. In
angiogenesis, hybrid tip/stalk phenotype, resulting
from higher production levels of Jagged, relates with
poorly perfused and chaotic angiogenesis based on
the theoretical framework for Notch-Delta-JaggedVEGF signaling [61]. But some evidence show that ICS
could be stable. Experimentally, H1975 lung cancer
cells can display a stable ICS over 2 months in culture
[28]. In addition, the landscape of the free energy
changes during EMT of the lung cancer cells shows a
stable intermediate state [34]. Not only in EMT, ICS of
immune system’s T-helper cells are also observed and
are stable, having two canonical subtypes [62].
Interestingly, computational modeling that considers the mutual inhibitory loops between several
miRNAs and EMT-TFs indicates that such networks
are capable of generating additional stable ICSs
[2, 24, 28] and have identified multiple phenotypic stability factors, such as Ovol, GRHL2, miR-145 [28] and
NUMB, that can stabilize an intermediate E/M phenotype [63]. What’s more, ICSs can be stabilized due to
the increase of gene expression noises [31, 64].

5. Rising issues and challenges
Recently, single-cell RNA sequencing (scRNASeq) has emerged as a powerful means to dissect the
heterogeneity in normal and diseased epithelial tissues.
The ability to sample the transcriptome and quantify
gene expression changes at single-cell resolution has
yielded unprecedented insights into the physiology
of epithelial systems by aiding in the discovery of rare
cell types, shedding light on the dynamics of lineage
differentiation, and providing comprehensive gene
expression profiles of diverse cell types [10, 65]. scRNASeq has also begun to be employed to better understand
5

the transition states that occur during EMT in cancer.
In a recent study, scRNA-Seq revealed the presence
of a partial EMT-like state in human squamous cell
carcinoma (SCC) samples, implicating the existence
of ICS in vivo. Another study utilized mouse models
of SCC and mammary tumorigenesis for single-cell
surface marker/RNA-seq analyses, and identified
subpopulations of tumor cells corresponding to
different degrees of EMT, with some displaying hybrid
phenotypes that likely represent multiple distinct ICSs
in vivo [66]. It is anticipated that single-cell approaches
will also reveal EMT-related heterogeneity and enable
the detection of ICSs in various normal epithelial
tissues. Indeed, sequencing of 1916 single cells from
eight different organs from E9.5 to E11.5 embryos led
to the identification of epithelial-mesenchymal ICSs in
all epithelial tissues sampled, including intestine, liver,
lung, and skin [67].
In addition to characterizing ICSs, single-cell
approaches have been used to suggest a role for
EMT and/or ICS in development/differentiation
and disease. Using an experimental pipeline that
incorporates single-cell qPCR analysis, it was shown
that human embryonic stem cells (hESCs) go through
a stepwise differentiation process into hepatocytes by
undergoing sequential EMT-MET with an obligatory
ICS, implicating a potential role for EMT/ICS in
hESC differentiation into a definitive endodermal
fate [68]. The SCC cells of the distinct ICSs discussed
above display different clonogenic and differentiation
potentials, as well as distinct invasive and plastic
properties, providing experimental evidence that
the different transition states that arise from EMT
progression have different biological functions [66].
It has become increasingly clear that ICSs during
EMT are important biological entities and must be
considered whenever EMT is studied. The exact roles
of EMT, and particularly of the constituent ICSs in
different developmental and disease contexts need to
be investigated using a combination of experimental
and computational approaches. It would be interesting
to computationally model the overall dynamics of the
cellular states in a continuum fashion to capture their
relatively unstable properties rather than studying
multiple statuses in between the main stable states.
Developing sophisticated computational tools that
facilitate the identification and characterization of
various ICSs—cell states that are more transient
and may be different from other major cell states—
represents a major challenge as well as opportunity in
the EMT field.
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